Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.
2.

Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.

Iwahashi N, Nakatani S, Umemura S, Kimura K, Kitakaze M.

J Am Soc Echocardiogr. 2011 Sep;24(9):984-91. doi: 10.1016/j.echo.2011.03.012.

PMID:
21570253
3.

B-type natriuretic peptide as a biochemical marker of left ventricular diastolic function: assessment in asymptomatic patients 1 year after valve replacement for aortic stenosis.

Mannacio V, Antignano A, De Amicis V, Di Tommaso L, Giordano R, Iannelli G, Vosa C.

Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):371-7. doi: 10.1093/icvts/ivt186.

4.

Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.

Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, Binder T, Pacher R, Maurer G, Baumgartner H.

Circulation. 2004 May 18;109(19):2302-8.

5.

Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.

Ben-Dor I, Minha S, Barbash IM, Aly O, Dvir D, Deksissa T, Okubagzi P, Torguson R, Lindsay J, Satler LF, Pichard AD, Waksman R.

Am J Cardiol. 2013 Aug 15;112(4):574-9. doi: 10.1016/j.amjcard.2013.04.023.

PMID:
23683951
6.

Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.

López-Otero D, Trillo-Nouche R, Gude F, Cid-Álvarez B, Ocaranza-Sanchez R, Alvarez MS, Lear PV, Gonzalez-Juanatey JR.

Int J Cardiol. 2013 Sep 30;168(2):1264-8. doi: 10.1016/j.ijcard.2012.11.116.

PMID:
23280329
7.

Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asymptomatic Patients With Aortic Stenosis.

Henri C, Dulgheru R, Magne J, Caballero L, Laaraibi S, Davin L, Kou S, Voilliot D, Nchimi A, Oury C, Pierard LA, Lancellotti P.

Can J Cardiol. 2016 Feb;32(2):183-9. doi: 10.1016/j.cjca.2015.06.007.

PMID:
26371385
8.

B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival.

Clavel MA, Malouf J, Michelena HI, Suri RM, Jaffe AS, Mahoney DW, Enriquez-Sarano M.

J Am Coll Cardiol. 2014 May 20;63(19):2016-25. doi: 10.1016/j.jacc.2014.02.581.

9.

Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Strain in Patients With Significant Aortic Stenosis.

Goodman A, Kusunose K, Popovic ZB, Parikh R, Barr T, Sabik JF, Rodriguez LL, Svensson LG, Griffin BP, Desai MY.

J Am Heart Assoc. 2016 Jan 5;5(1). pii: e002561. doi: 10.1161/JAHA.115.002561.

10.

Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis.

Pedrazzini GB, Masson S, Latini R, Klersy C, Rossi MG, Pasotti E, Faletra FF, Siclari F, Minervini F, Moccetti T, Auricchio A.

Am J Cardiol. 2008 Sep 15;102(6):749-54. doi: 10.1016/j.amjcard.2008.04.055.

PMID:
18774001
11.

Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation.

Kefer J, Beauloye C, Astarci P, Renkin J, Glineur D, Dekleermaeker A, Vanoverschelde JL.

Am J Cardiol. 2010 Dec 15;106(12):1782-6. doi: 10.1016/j.amjcard.2010.07.051.

PMID:
21055712
12.

B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement.

Nozohoor S, Nilsson J, Lührs C, Roijer A, Algotsson L, Sjögren J.

J Cardiothorac Vasc Anesth. 2009 Apr;23(2):161-5. doi: 10.1053/j.jvca.2008.11.006.

PMID:
19167912
13.

Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.

Antonini-Canterin F, Popescu BA, Popescu AC, Beladan CC, Korcova R, Piazza R, Cappelletti P, Rubin D, Cassin M, Faggiano P, Nicolosi GL.

Int J Cardiol. 2008 Aug 29;128(3):406-12.

PMID:
17662495
14.

Recovery after balloon aortic valvuloplasty in patients with aortic stenosis and impaired left ventricular function: predictors and prognostic implications.

Kefer J, Gapira JM, Pierard S, De Meester C, Gurne O, Chenu P, Renkin J.

J Invasive Cardiol. 2013 May;25(5):235-41.

15.

B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.

Gotzmann M, Czauderna A, Aweimer A, Hehnen T, Bösche L, Lind A, Kloppe A, Mügge A, Ewers A.

J Heart Valve Dis. 2014 Sep;23(5):537-44.

PMID:
25799701
16.

Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.

Koskinas KC, O'Sullivan CJ, Heg D, Praz F, Stortecky S, Pilgrim T, Buellesfeld L, Jüni P, Windecker S, Wenaweser P.

Am J Cardiol. 2015 Nov 15;116(10):1560-5. doi: 10.1016/j.amjcard.2015.08.016.

PMID:
26428025
17.

Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis.

Lancellotti P, Moonen M, Magne J, O'Connor K, Cosyns B, Attena E, Donal E, Pierard L.

Am J Cardiol. 2010 Feb 1;105(3):383-8. doi: 10.1016/j.amjcard.2009.09.043.

PMID:
20102953
18.

Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis.

Weber M, Hausen M, Arnold R, Nef H, Moellman H, Berkowitsch A, Elsaesser A, Brandt R, Mitrovic V, Hamm C.

Heart. 2006 Nov;92(11):1639-44.

19.

Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.

Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V, Hamm C.

Am J Cardiol. 2004 Sep 15;94(6):740-5.

PMID:
15374777
20.

Supplemental Content

Support Center